OMNIAB, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
OMNIAB, INC. (OABI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 64.04 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 64.40M shares, a 2.92% increase year-over-year.
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 62.57M shares, a 2.39% increase year-over-year.
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 61.11M shares, a 5.97% increase year-over-year.
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 57.67M shares.
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 59.84M shares, a 0.01% decline from fiscal 2024.
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 59.84M shares, a 0.06% increase from fiscal 2023.
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 59.81M shares, a 5.61% increase from fiscal 2022.
- OMNIAB, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 56.63M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 64.04M shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 64.40M shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 59.84M shares 10-K · filed 2026-03-04 | |||
| 2025-09-30 | 61.23M shares 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 62.02M shares 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 62.57M shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 59.84M shares 10-K · filed 2026-03-04 | |||
| 2024-09-30 | 60.29M shares 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | 60.58M shares 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | 61.11M shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 59.81M shares 10-K · filed 2025-03-18 | |||
| 2023-09-30 | 60.15M shares 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 60.92M shares 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | 57.67M shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 56.63M shares 10-K · filed 2024-03-25 | |||
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |